Thursday, November 19, 2009
AstraZeneca applies for US approval for blood clot preventer Brilinta
LONDON - AstraZeneca PLC said Thursday it has applied to U.S. regulators to market its blood clot preventer Brilinta, a potential new big seller for the company. AstraZeneca submitted a new drug application to the U.S....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment